An innovative service aimed at enhancing the profile and increasing liquidity of AIM and small cap PLCs.

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/6/10/7/80a8465e-4ab5-4d12-85d5-c103855e32e2_purdy-pod.mp3

Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk to discuss its latest trading update. Graeme explains how it’s large format Goliath programme has continued largely unaffected by COVID restrictions, with partners such as JLR and McLaren being more affected by COVID what impact this has had on the company, whats happening with the Stereax pilot line for making miniature batteries, plans for transferring Stereax to a 3rd party FAB and with full year results due soon how investors can interact with the company to discuss these.

Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk to discuss its latest trading update. Graeme explains how it’s large format Goliath programme has continued largely unaffected by COVID restrictions, with partners such as JLR and McLaren being more affected by COVID what impact this has had on the company, whats happening with the Stereax pilot line for making miniature batteries, plans for transferring Stereax to a 3rd party FAB and with full year results due soon how investors can interact with the company to discuss these.

Ilika Boss Graeme Purdy looking to ramp up productivity

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/6/1/8/1d62cf3a-f700-4743-bc28-cff3ed623734_phil-pod.mp3

Hardide plc (LON:HDD) CEO Philip Kirkham joins DirectorsTalk to discuss interim results for the six-month period ended 31 March 2020. Philip explains what has driven another record set of numbers, talks about the first production order for Airbus A380 wing compression pads, other orders in the aerospace sector, how the move to Bicester, Oxfordshire is progressing, how the company has been affected by COVID 19 and the outlook for the year ahead.

Hardide plc (LON:HDD) CEO Philip Kirkham joins DirectorsTalk to discuss interim results for the six-month period ended 31 March 2020. Philip explains what has driven another record set of numbers, talks about the first production order for Airbus A380 wing compression pads, other orders in the aerospace sector, how the move to Bicester, Oxfordshire is progressing, how the company has been affected by COVID 19 and the outlook for the year ahead.

Hardide Delivering record sales revenues again

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/6/1/8/50a13c66-2f17-49de-9bf5-205b787c3555_a-pod.mp3

Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss preliminary results for the period ending 31st Dec 2019. Alastair talks us through the highlights, outlines the key objectives to the coming 12 to 18 months and reminds us of what has been achieved over the past 12 months.

Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss preliminary results for the period ending 31st Dec 2019. Alastair talks us through the highlights, outlines the key objectives to the coming 12 to 18 months and reminds us of what has been achieved over the past 12 months.

Avacta Group CEO says ‘Substantial long term and sustainable value growth for shareholders’

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/6/1/8/c023d654-4372-4337-8d29-ce4408b2c755_cog-pod.mp3

Cambridge Cognition plc (LON:COG) CEO Matthew Stork joins DirectorsTalk to chat about preliminary results for 2019. Matthew talks us through the highlights, explains why Q1 2020 order intake has been so positive, the impact of COVID-19 and shares his thoughts on the coming months and the future for the company.

Cambridge Cognition plc (LON:COG) CEO Matthew Stork joins DirectorsTalk to chat about preliminary results for 2019. Matthew talks us through the highlights, explains why Q1 2020 order intake has been so positive, the impact of COVID-19 and shares his thoughts on the coming months and the future for the company.

Cambridge Cognition CEO Matthew Stork Excited over potential for growth

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/28/8/8a87dce6-f1d6-40bb-bd03-ffaf4dd0429d_ben-pod.mp3

CentralNic Group plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk to discuss final results for the year ended 31st Dec 2019 and Q1 2020. Ben talks us through the financial performance for the year, explains what kind of growth they have seen over the first quarter, the effects of COVID-19, why its important that 50% of revenues are coming from domain related services and how the integration of both Team Internet and the new hires is going. CentralNic Group is a London-based AIM-listed company which drives the growth of the global digital economy by developing and managing software platforms allowing businesses globally to buy subscriptions to domain names, used for their own websites and email, as well as for protecting their brands online. Its core growth strategy is identifying and acquiring cash-generative businesses in its industry with annuity revenue streams and exposure to growth markets and migrating them onto the CentralNic software and operating platforms. The company operates globally with customers in almost every country in the world. It earns recurring revenues from the worldwide sales of internet domain names and other services on an annual subscription basis.

CentralNic Group plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk to discuss final results for the year ended 31st Dec 2019 and Q1 2020. Ben talks us through the financial performance for the year, explains what kind of growth they have seen over the first quarter, the effects of COVID-19, why its important that 50% of revenues are coming from domain related services and how the integration of both Team Internet and the new hires is going.

CentralNic Group Strong Performance with Another Doubling of Profits

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/24/7/564dfd82-4a6d-473c-bea1-5c4afc42fcf9_c-pod.mp3

Open Orphan plc (LON:ORPH) CEO Cathal Friel joins DirectorsTalk to discuss the testing of an anti-viral for treating COVID-19. Cathal explains whats involved in the testing, the time frames involved and what investors should expect over the coming months and weeks.  Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe&#39;s only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary&#39;s Hospital London. hVIVO supports product development for customers developing antivirals, vaccines and respiratory therapeutics, all particularly relevant and topical in the environment of heightened awareness of Covid-19 in 2020. The Company also has a leading portfolio of 8 viral challenge study models which are: 2 FLU, 2 RSV, 1 HRV, 1 Asthma, 1 cough and 1 COPD viral challenge models. As announced in early March, Open Orphan is rapidly advancing a Coronavirus challenge study model and expects to be very active with many companies in the development of a Covid-19 vaccine. No other company in the world has such a portfolio, with only two competitors globally having 1 challenge study model each.  Open Orphan comprises of two commercial specialist CRO services businesses (Venn and hVIVO) and is developing an early stage orphan drug genomics data platform business. This platform captures valuable genetic data from patient populations with specific diseases with designated orphan drug status and incorporating AI tools. In June 2019, Open Orphan acquired AIM-listed Venn Life Sciences Holdings plc in a reverse take-over and in January 2020 it completed the merger with hVIVO plc. Venn, as an integrated drug development consultancy, offers CMC (chemistry, manufacturing and controls), preclinical, Phase I &amp; II clinical trials design and execution. The merger with hVIVO created a European full pharma services company broadening the Company&#39;s customer base and with complementary specialist CRO services, widened the range of the Company&#39;s service offerings.

Open Orphan plc (LON:ORPH) CEO Cathal Friel joins DirectorsTalk to discuss the testing of an anti-viral for treating COVID-19. Cathal explains whats involved in the testing, the time frames involved and what investors should expect over the coming months and weeks.

Open Orphan CEO Cathal Fiel ‘Expect some quite substantial contracts’

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/24/7/aa57a702-1bdc-4218-906d-6a3e38372fb8_davis-pod.mp3

NQ Minerals plc (AQUIS: NQMI) (OTCQB: NQMLF) Chairman David Lenigas joins DirectorsTalk to discuss the significantly expanded Nickel resource in Tasmania. David talks us through the highlights, expands on the long-term plans for the Beaconsfield region, touches on speaking to off-takers and battery industry players and what investors can expect from NQ Minerals in the coming months.

NQ Minerals plc (AQUIS: NQMI) (OTCQB: NQMLF) Chairman David Lenigas joins DirectorsTalk to discuss the significantly expanded Nickel resource in Tasmania. David talks us through the highlights, expands on the long-term plans for the Beaconsfield region, touches on speaking to off-takers and battery industry players and what investors can expect from NQ Minerals in the coming months.

NQ Minerals Chairman David Lenigas says ‘in deep discussions with off-takers’

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/22/6/7182d0aa-587c-4f72-9ead-485e39a41547_mike-pod.mp3

Surface Transforms plc (LON:SCE) is the topic of conversation when Hardman &amp; Co Analyst Mike Foster joins us. Mike explains what the company does, the market place, suppliers, how big the company will get, profits, risks and why the company valuation looks so favourable.

Surface Transforms plc (LON:SCE) is the topic of conversation when Hardman & Co Analyst Mike Foster joins us. Mike explains what the company does, the market place, suppliers, how big the company will get, profits, risks and why the company valuation looks so favourable.

Surface Transforms High visibility for 2021 onwards (Analyst Interview)

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/21/14/ddf80785-c5b4-40c3-8721-448d883ade15_leon_pod.mp3

Jubilee Metals Group plc (LON:JLP) CEO Leon Coetzer joins DirectorsTalk to discuss the impact of COVID 19. Leon touches on the highlights of the latest interim results, the effect of COVID 19 and his optimism for the future.

Jubilee Metals Group plc (LON:JLP) CEO Leon Coetzer joins DirectorsTalk to discuss the impact of COVID 19. Leon touches on the highlights of the latest interim results, the effect of COVID 19 and his optimism for the future.

Jubilee Metals CEO Leon Coetzer, Strategy, COVID19, Strength & Opportunity

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/21/8/05552732-9aee-43e8-b441-d17992d9ae05_phil-pod.mp3

Hardide plc (LON:HDD) CEO Philip Kirkham joins DirectorsTalk to discuss being honoured with a Queen’s Award for Enterprise in recognition of the outstanding growth of its international sales. Phil provides more details around the award, explains why they applied for it and whats next for Hardide internationally.

Hardide plc (LON:HDD) CEO Philip Kirkham joins DirectorsTalk to discuss being honoured with a Queen’s Award for Enterprise in recognition of the outstanding growth of its international sales. Phil provides more details around the award, explains why they applied for it and whats next for Hardide internationally.

Hardide CEO Philip Kirkham Extremely Pleased with International Growth Recognition

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/16/7/ca961ffa-3989-4b3d-acce-9064f9d688c3_david-pod.mp3

Surface Transforms plc (LON:SCE) Chairman David Bundred joins DirectorsTalk to discuss the effects of COVID 19 and a recent fund raise. First David explains whats is going on at Surface Transforms, where they are headed, the effect on customers, the effect on the company, why money has been raised and why now an open offer. Surface Transforms are experts in the development and production of carbon-ceramic materials and the UK’s only manufacturer of carbon-ceramic brakes for automotive use. ST utilises our proprietary next-generation carbon-ceramic material – CCST – to create lightweight brake discs for high-performance applications, including automotive and aircraft brakes. Surface Transforms has extensive in-house engineering and manufacturing capabilities, including the facilities for manufacturing carbon-ceramic brake discs. While conventional carbon-ceramic brake discs use discontinuous (chopped) carbon fibre, ST interweaves continuous carbon fibre to form a 3D matrix, producing a stronger and more durable product with 3x the heat conductivity compared to our competitors; this reduces the brake system operating temperature, resulting in increased life of components with the same brake performance. Surface Transforms’ unique patented Carbon-Ceramic technology provides the ultimate braking performance for road and track.

Surface Transforms plc (LON:SCE) Chairman David Bundred joins DirectorsTalk to discuss the effects of COVID 19 and a recent fund raise. First David explains whats is going on at Surface Transforms, where they are headed, the effect on customers, the effect on the company, why money has been raised and why now an open offer.

Surface Transforms: David Bundred ‘An astonishing 6 weeks but in good shape for next 6 years’

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/9/7/e2eeb9c1-d9cd-40af-99f4-980fe15d85a2_al-pod.mp3

Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss the development and manufacture of a rapid test for the COVID-19 coronavirus infection for population screening. Alastair explains what the test will be able to do, why the Affimer platform is ideal for developing this kind of diagnostic, the commercial terms of the agreement and when we should expect the test to be available. Avacta Group is developing novel cancer immunotherapies combining its two proprietary platforms – Affimer® biotherapeutics and pre|CISION™ tumour targeted chemotherapy. With this approach, the Company aims to address the lack of a durable response to current immunotherapies experienced by most patients. The Company’s therapeutics development activities are based in Cambridge, UK. The Affimer platform is an alternative to antibodies derived from a small human protein. Despite their shortcomings, antibodies currently dominate markets worth in excess of $100bn. Affimer technology has been designed to address many of these negative performance issues, principally: the time taken, and the reliance on an animal’s immune response, to generate new antibodies; poor specificity in many cases; large size and cost. Avacta has established drug development partnerships with pharma and biotech, including with Moderna Therapeutics Inc., a deal with LG Chem worth up to $310m, a partnership with ADC Therapeutics to develop Affimer drug conjugates and has established a joint venture in South Korea with Daewoong Pharmaceutical focused on cell and gene therapies incorporating Affimer immune-modulators. Avacta actively seeks to license its proprietary platforms in a range of therapeutic areas. Avacta diagnostics business unit works with partners world-wide to develop Affimers for evaluation by those third parties with the objective of establishing royalty bearing license deals. The Company is also developing a small in-house pipeline of Affimer-based diagnostic assays for licensing.

Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss the development and manufacture of a rapid test for the COVID-19 coronavirus infection for population screening. Alastair explains what the test will be able to do, why the Affimer platform is ideal for developing this kind of diagnostic, the commercial terms of the agreement and when we should expect the test to be available.

Avacta Group CEO Alastair Smith Rapid COVID19 Test Strips Available Summer

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/8/7/0f0650f9-ea84-4317-94b2-3feb43bbc167_ben-pod.mp3

CentralNic Group plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk to discuss an internal leadership restructuring new key appointments and its COVID 19 update. Ben talks us through the changes, the key messages from the update and explains what makes CentralNic Group so resilient. CentralNic Group is a London-based AIM-listed company which drives the growth of the global digital economy by developing and managing software platforms allowing businesses globally to buy subscriptions to domain names, used for their own websites and email, as well as for protecting their brands online. Its core growth strategy is identifying and acquiring cash-generative businesses in its industry with annuity revenue streams and exposure to growth markets and migrating them onto the CentralNic software and operating platforms. CentralNic operates globally with customers in almost every country in the world. It earns recurring revenues from the worldwide sales of internet domain names and other services on an annual subscription basis.

CentralNic Group plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk to discuss an internal leadership restructuring new key appointments and its COVID 19 update. Ben talks us through the changes, the key messages from the update and explains what makes CentralNic Group so resilient.

CentralNic Group CEO Ben Crawford restructuring for further growth

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/8/7/21a34ecd-726d-4734-a083-e0d2d1c8b13b_david-pod.mp3

NQ Minerals plc (AQUIS: NQMI) (OTCQB: NQMLF) Chairman David Lenigas joins DirectorsTalk to discuss Q1 2020 production figures and its COVID-19 response plan. David talks us through the highlights, expands on the response plan, explains what the update on the Beaconsfield Gold Mine means for the company and other news that investors can expect over the coming months.

NQ Minerals plc (AQUIS: NQMI) (OTCQB: NQMLF) Chairman David Lenigas joins DirectorsTalk to discuss Q1 2020 production figures and its COVID-19 response plan. David talks us through the highlights, expands on the response plan, explains what the update on the Beaconsfield Gold Mine means for the company and other news that investors can expect over the coming months.

NQ Minerals Chair David Lenigas ‘operating as normal and producing good results’

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/8/7/5165bc2f-4478-40ce-a1f8-0f958b143576_david-s-pod.mp3

Zotefoams plc (LON:ZTF) CEO David Stirling joins DirectorsTalk to discuss preliminary results for the year ended 31 December 2019. David talks us through the financial highlights, expands on he HPP strategy, explains how MuCell has made a return to growth, a new opportunity in ReZorce mono-material barrier packaging, the launch of A-ZOTE Adapt and how David view the outlook for the company. Zotefoams plc is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide. Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

Zotefoams plc (LON:ZTF) CEO David Stirling joins DirectorsTalk to discuss preliminary results for the year ended 31 December 2019. David talks us through the financial highlights, expands on he HPP strategy, explains how MuCell has made a return to growth, a new opportunity in ReZorce mono-material barrier packaging, the launch of A-ZOTE Adapt and how David view the outlook for the company.

Zotefoams CEO David Stirling Says ‘Performing well, in line with strategy’

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/7/8/202c4eb9-3b26-4162-b924-102a1ab5117b_gervais-pod.mp3

Premier Miton Group plc (LON:PMI) Head of Equities, Gervais Williams joins DirectorsTalk to discuss the investment process, meeting companies, company indicators, reporting of climate risks and how companies mitigate them. Premier Miton was formed in November 2019 from the merger of Premier Asset Management Group plc and Miton Group plc. It manages £11billion on behalf of a wide range of individual investors and institutions. The merger has brought together the capabilities, expertise and knowledge of two highly regarded companies to create a new organisation that is even better placed to deliver the right outcomes for its clients. The asset management industry is facing a time of unparalleled challenges, particularly in its ability to deliver value to its underlying clients. Its Premier Miton’s belief that genuinely active management can make a real difference to investment returns.

Premier Miton Group plc (LON:PMI) Head of Equities, Gervais Williams joins DirectorsTalk to discuss the investment process, meeting companies, company indicators, reporting of climate risks and how companies mitigate them.


Premier Miton was formed in November 2019 from the merger of Premier Asset Management Group plc and Miton Group plc. It manages £11billion on behalf of a wide range of individual investors and institutions.

Premier Miton’s Gervais Williams looks at the Investment Process, Indicators and Climate Change

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/4/3/6/8f04aff9-b2f4-4140-aa14-ad56511ee07e_steve-pod.mp3

Manolete Partners (LON:MANO) CEO Steven Cooklin joins DirectorsTalk to discuss the impact of COVID-19. Steven explains the impact both short-term, longer, the competition and its market share. Manolete Partners Plc is a specialist insolvency litigation financing company. The company funds or buys insolvency claims. They work with Insolvency Practitioners and their lawyers to maximise returns to creditors and are renowned for our unparalleled knowledge of the Insolvency and Recovery sector.

A positive outlook for Manolete Partners

Manolete Partners (LON:MANO) CEO Steven Cooklin joins DirectorsTalk to discuss the impact of COVID-19. Steven explains the impact both short-term, longer, the competition and its market share.

Manolete Partners Plc is a specialist insolvency litigation financing company. The company funds or buys insolvency claims. They work with Insolvency Practitioners and their lawyers to maximise returns to creditors and are renowned for our unparalleled knowledge of the Insolvency and Recovery sector.

Manolete Partners CEO Steven Cooklin explains why the outlook is looking so good

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/3/31/7/8993d47a-a13a-40d7-9ea9-e43501999c05_mark-pod.mp3

RM Secured Direct Lending Plc (LON:RMDL) is the topic of conversation when Mark Thomas, Analyst at Hardman &amp; Co joins DirectorsTalk. Mark explains the key message from his recent note on the company, how the company portfolio is faring in the current market turmoil and Marks thoughts on a recent Q&amp;A with the manager over credit. RM Secured Direct Lending Plc is a closed-ended investment trust established to invest in a portfolio of secured debt instruments. The Company aims to generate attractive and regular dividends through loans sourced or originated by the Investment Manager with a degree of inflation protection through index-linked returns where appropriate. Loans in which the Company invests are predominantly secured against assets such as real estate or plant and machinery and/or income streams such as account receivables.

RM Secured Direct Lending Plc (LON:RMDL) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk. Mark explains the key message from his recent note on the company, how the company portfolio is faring in the current market turmoil and Marks thoughts on a recent Q&A with the manager over credit.

RM Secured Direct Lending Reduced Volatility and Above Average Yields (Hardman & Co)

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/3/27/11/cd3eec80-ce50-44dc-a09d-2303debd8564_tony-pod.mp3

Gresham House plc (LON:GHE) CEO Tony Dalwood joins DirectorsTalk to discuss becoming investment manager and Alternative Investment Fund Manager of Strategic Equity Capital plc. Tony explains the detail of the deal, why the SPE style of investing is important for this mandate, why the partnership between Gresham House and Aberdeen Standard Investments is special and what this mandate means for GHE going forward. Gresham House plc is an AIM quoted specialist asset manager providing funds, direct investments and tailored investment solutions, including co-investment across a range of highly differentiated alternative investment strategies. Our expertise includes timber, renewable energy, housing and infrastructure, strategic public and private equity (private assets). The group aims to deliver sustainable financial returns and is committed to building long-term partnerships with clients (institutions, family offices, high-net-worth individuals, charities and endowments and private individuals) to help them achieve their financial goals. Shareholder value creation will be driven by long-term growth in earnings as a result of increasing AUM and returns from invested capital.

Gresham House plc (LON:GHE) CEO Tony Dalwood joins DirectorsTalk to discuss becoming investment manager and Alternative Investment Fund Manager of Strategic Equity Capital plc. Tony explains the detail of the deal, why the SPE style of investing is important for this mandate, why the partnership between Gresham House and Aberdeen Standard Investments is special and what this mandate means for GHE going forward.



Gresham House plc is an AIM quoted specialist asset manager providing funds, direct investments and tailored investment solutions, including co-investment across a range of highly differentiated alternative investment strategies. Our expertise includes timber, renewable energy, housing and infrastructure, strategic public and private equity (private assets). The group aims to deliver sustainable financial returns and is committed to building long-term partnerships with clients (institutions, family offices, high-net-worth individuals, charities and endowments and private individuals) to help them achieve their financial goals.



Shareholder value creation will be driven by long-term growth in earnings as a result of increasing AUM and returns from invested capital.

Gresham House CEO Tony Dalwood Further Evidence of Growing Organically

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/3/27/9/3c29ec2b-dd40-4eef-8fcd-abcb6ba67e00_paulbaay-pod.mp3

Touchstone Exploration Inc. (LON:TXP) CEO Paul Baay joins DirectorsTalk to discuss year end results. Paul talks us through the highlights, progress at COHO and Cascadura, when we can expect results from Chinook, the effect of COVID 19 and volatility in the market.  Touchstone Exploration is a Calgary based company engaged in the business of acquiring interests in petroleum and natural gas rights and the exploration, development, production and sale of petroleum and natural gas. Touchstone is currently active in onshore properties located in the Republic of Trinidad and Tobago. The Company&#39;s common shares are traded on the Toronto Stock Exchange and the AIM market of the London Stock Exchange.

Touchstone Exploration Inc. (LON:TXP) CEO Paul Baay joins DirectorsTalk to discuss year end results. Paul talks us through the highlights, progress at COHO and Cascadura, when we can expect results from Chinook, the effect of COVID 19 and volatility in the market. 



Touchstone Exploration in Good Shape, Excited for 2021 says CEO Paul Baay

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/3/27/7/250268f8-eaad-4be6-933e-65dc21aa356e_jonp-pod.mp3

Boku Inc. (LON:BOKU) CEO Jon Prideaux joins DirectorsTalk to discuss results for the year ended 31st December 2019. Jon explains the trends he is seeing during the impact of COVID-19, talks us through the highlights of 2019 and what we can look forward to during 2020. ﻿Boku&#39;s technology platform is used in over 59 countries with over 815 million verified transactions in 2019, contributing $5 billion to the digital economy. Businesses that currently employ Boku&#39;s platform to simplify sign-up, acquire new paying users and prevent fraud include global leaders such as Apple, Discover, Experian, Facebook, Fiserv, Google, Microsoft, Netflix, PayPal, Sony, Spotify, Uber and Western Union.

Boku Inc CEO Jon Prideaux Talks Increased Volume and Trends

Boku Inc. (LON:BOKU) CEO Jon Prideaux joins DirectorsTalk to discuss results for the year ended 31st December 2019. Jon explains the trends he is seeing during the impact of COVID-19, talks us through the highlights of 2019 and what we can look forward to during 2020.

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/3/26/7/407d13f4-2326-4e06-a1ad-1d9658ae3aa6_gpurdy-pod.mp3

Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk to discuss its effective remote working practices and how it can minimise any impact from COVID-19. Graeme explains the kind of activities the battery development team can carry out, the effect of a global travel lock-down, operational capability, confidence for the next 3 financial years and why Ilika shares have been so resilient.

Ilika plc CEO Graeme Purdy Confident as Stereax plans remain on track

Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk to discuss its effective remote working practices and how it can minimise any impact from COVID-19. Graeme explains the kind of activities the battery development team can carry out, the effect of a global travel lock-down, operational capability, confidence for the next 3 financial years and why Ilika shares have been so resilient.

https://s3.us-east-2.amazonaws.com/pod-public-media-files/2020/3/25/10/60d53abe-c9c3-496d-8c4b-b1e39f457d54_agm-podcast.mp3

Applied Graphene Materials plc (LON:AGM) CEO Adrian Potts joins DirectorsTalk to discuss interim results for the six months ended 31st January 2020. Adrian talks us through the highlights, points out areas that investors should look at, the importance of data, what to expect over the coming period and how COVID-19 is impacting the business.

Significant progress at Applied Graphene Materials

Applied Graphene Materials plc (LON:AGM) CEO Adrian Potts joins DirectorsTalk to discuss interim results for the six months ended 31st January 2020. Adrian talks us through the highlights, points out areas that investors should look at, the importance of data, what to expect over the coming period and how COVID-19 is impacting the business.

Applied Graphene Materials CEO Adrian Potts Shares the Significant progress made

AIM and Small Cap PLC Interviews

DirectorsTalk Interviews is an innovative service aimed at enhancing the profile and increasing liquidity of AIM and small cap PLCs.

DirectorsTalk Interviews

Episodes

Ilika Boss Graeme Purdy looking to ramp up productivity

Hardide Delivering record sales revenues again

Avacta Group CEO says ‘Substantial long term and sustainable value growth for shareholders’

Cambridge Cognition CEO Matthew Stork Excited over potential for growth

CentralNic Group Strong Performance with Another Doubling of Profits

Open Orphan CEO Cathal Fiel ‘Expect some quite substantial contracts’

NQ Minerals Chairman David Lenigas says ‘in deep discussions with off-takers’

Surface Transforms High visibility for 2021 onwards (Analyst Interview)

Jubilee Metals CEO Leon Coetzer, Strategy, COVID19, Strength & Opportunity

Hardide CEO Philip Kirkham Extremely Pleased with International Growth Recognition

Surface Transforms: David Bundred ‘An astonishing 6 weeks but in good shape for next 6 years’

Avacta Group CEO Alastair Smith Rapid COVID19 Test Strips Available Summer

CentralNic Group CEO Ben Crawford restructuring for further growth

NQ Minerals Chair David Lenigas ‘operating as normal and producing good results’

Zotefoams CEO David Stirling Says ‘Performing well, in line with strategy’

Premier Miton’s Gervais Williams looks at the Investment Process, Indicators and Climate Change

Manolete Partners CEO Steven Cooklin explains why the outlook is looking so good

RM Secured Direct Lending Reduced Volatility and Above Average Yields (Hardman & Co)

Gresham House CEO Tony Dalwood Further Evidence of Growing Organically

Touchstone Exploration in Good Shape, Excited for 2021 says CEO Paul Baay

Boku Inc CEO Jon Prideaux Talks Increased Volume and Trends

Ilika plc CEO Graeme Purdy Confident as Stereax plans remain on track

Applied Graphene Materials CEO Adrian Potts Shares the Significant progress made

Related Shows